Ascletis Pharma Inc. (ASCLF)
USD 0.62
(0.0%)
USD 0.62
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -144.71 Million CNY | 54.04% |
| 2022 | -314.84 Million CNY | -58.2% |
| 2021 | -199.01 Million CNY | 4.89% |
| 2020 | -209.24 Million CNY | -118.03% |
| 2019 | -95.96 Million CNY | -1222.25% |
| 2018 | -7.25 Million CNY | 86.54% |
| 2017 | -53.93 Million CNY | -101.2% |
| 2016 | -26.8 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 FY | -144.71 Million CNY | 54.04% |
| 2023 Q4 | -17.72 Million USD | 0.0% |
| 2023 Q2 | -2.38 Million USD | 0.0% |
| 2022 FY | -314.84 Million CNY | -58.2% |
| 2022 Q2 | -13.53 Million USD | 0.0% |
| 2022 Q4 | -32.58 Million USD | 0.0% |
| 2021 Q2 | -17.12 Million USD | 0.0% |
| 2021 Q4 | -13.68 Million USD | 0.0% |
| 2021 FY | -199.01 Million CNY | 4.89% |
| 2020 FY | -209.24 Million CNY | -118.03% |
| 2020 Q2 | -7.32 Million USD | 0.0% |
| 2020 Q4 | -23.28 Million USD | 0.0% |
| 2019 Q4 | -6.96 Million USD | 0.0% |
| 2019 FY | -95.96 Million CNY | -1222.25% |
| 2019 Q2 | -6.98 Million USD | 0.0% |
| 2018 Q2 | 22.49 Million CNY | 93.45% |
| 2018 FY | -7.25 Million CNY | 86.54% |
| 2018 Q1 | 11.62 Million CNY | 0.0% |
| 2017 Q2 | -14.91 Million CNY | -484.98% |
| 2017 FY | -53.93 Million CNY | -101.2% |
| 2017 Q1 | -2.55 Million CNY | 0.0% |
| 2016 FY | -26.8 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 52.97 Million USD | 373.155% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 322.184% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -811.795% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -1972.439% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -10736.576% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -22783.207% |
| Nascent Biotech, Inc. | -2.08 Million USD | -6831.851% |
| Qrons Inc. | -789.34 Thousand USD | -18233.509% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -131.178% |
| Skye Bioscience, Inc. | -37.64 Million USD | -284.422% |
| BioStem Technologies, Inc. | -8.48 Million USD | -1605.945% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -34730.882% |
| Regen BioPharma, Inc. | 1.02 Million USD | 14239.118% |
| Rebus Holdings, Inc. | -1.02 Million USD | -14087.745% |
| CSL Limited | 2.64 Billion USD | 105.477% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -3689.343% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -93.049% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -2100.617% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -52831.215% |
| SQZ Biotechnologies Company | -79.46 Million USD | -82.114% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -4903.295% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -7849.068% |
| Mesoblast Limited | -87.95 Million USD | -64.531% |
| Marizyme, Inc. | -65.34 Million USD | -121.457% |
| Genus plc | 7.9 Million USD | 1931.835% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -1228.667% |
| Pharming Group N.V. | -10.54 Million USD | -1271.966% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -6569.466% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -3800.428% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -1536.307% |
| ContraFect Corporation | -65.15 Million USD | -122.116% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -2861.792% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -8277.353% |
| IMV Inc. | -36.48 Million USD | -296.635% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -1695.542% |
| MultiCell Technologies, Inc. | -380.07 USD | -38075780.759% |
| ONE Bio Corp. | 8.67 Million USD | 1767.875% |
| Accustem Sciences Inc. | -3.74 Million USD | -3762.755% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -179.956% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -11320.655% |
| Q BioMed Inc. | -2.05 Million USD | -6952.068% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -3776.641% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -5978.24% |
| Biomind Labs Inc. | -1.21 Million USD | -11817.379% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -142.301% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -4565.565% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -1731.119% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -7324.141% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -966212.767% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -2387.686% |
| GB Sciences, Inc. | -1.36 Million USD | -10527.704% |
| Alpha Cognition Inc. | -13.77 Million USD | -950.748% |
| HST Global, Inc. | -146.21 Thousand USD | -98877.498% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -8146.945% |
| Halberd Corporation | -79.67 Thousand USD | -181529.349% |
| Enzolytics Inc. | -2.17 Million USD | -6547.964% |
| Agentix Corp. | -1.37 Million USD | -10430.77% |
| Resverlogix Corp. | -3.61 Million USD | -3908.726% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -4463.075% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 50.953% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 147768.367% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 2189.87% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -3542.468% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -4682.173% |
| AVAX Technologies, Inc. | -6.41 Million USD | -2156.36% |
| Zenith Capital Corp. | -10.59 Million USD | -1265.751% |
| Genscript Biotech Corporation | -95.47 Million USD | -51.571% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -622544.351% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -3390.527% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -239333.388% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -7117.292% |
| Kadimastem Ltd | -3.3 Million USD | -4275.494% |
| Helix BioMedix, Inc. | -1.05 Million USD | -13603.332% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -32687.758% |
| LadRx Corporation | 400.44 Thousand USD | 36238.726% |
| Cell Source, Inc. | -5.32 Million USD | -2619.587% |
| Regen BioPharma, Inc. | 1.02 Million USD | 14239.118% |
| NovAccess Global Inc. | -4.76 Million USD | -2934.375% |
| Affymax, Inc. | -14.42 Million USD | -903.293% |
| Itoco Inc. | -1.86 Million USD | -7642.931% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -3157.487% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -8570.761% |
| Mobile Lads Corp. | -2.26 Million USD | -6294.005% |
| CytoDyn Inc. | -49.84 Million USD | -190.353% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -183007.057% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -63336.156% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -15270.212% |
| SYBLEU INC | -180.3 Thousand USD | -80161.669% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -8873.255% |
| International Stem Cell Corporation | -131 Thousand USD | -110369.466% |
| Bioxytran, Inc. | -4.28 Million USD | -3281.19% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -266547.627% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -5619.402% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -201.038% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -6745.553% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -18432.131% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -4468.024% |
| Neutra Corp. | -233.46 Thousand USD | -61885.737% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -613.198% |
| PureTech Health plc | -65.69 Million USD | -120.276% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -580.482% |
| IXICO plc | -1.17 Million USD | -12184.805% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -1357.792% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -153.317% |
| CSL Limited | 2.64 Billion USD | 105.477% |
| Cellectis S.A. | -103.17 Million USD | -40.263% |